Evidence map›Paper›PMID 27876801›Full record

ArticleNature communications2016

PPFIA1 drives active α5β1 integrin recycling and controls fibronectin fibrillogenesis and vascular morphogenesis.

Giulia Mana, Fabiana Clapero, Emiliano Panieri, Valentina Panero, Ralph T Böttcher, Hui-Yuan Tseng, Federico Saltarin, Elena Astanina, Katarzyna I Wolanska, Mark R Morgan and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Liprin-α family proteins and their cellular functions.The Journal of biological chemistry · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 4 countries.

Giulia ManaDepartment of Oncology, University of Torino School of Medicine, Candiolo, Torino 10060, Italy.
Fabiana ClaperoDepartment of Oncology, University of Torino School of Medicine, Candiolo, Torino 10060, Italy.
Emiliano PanieriDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, 10126 Torino, Italy.
Valentina PaneroDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, 10126 Torino, Italy.
Ralph T BöttcherDepartment of Molecular Medicine, Max Planck Institute of Biochemistry, Martinsried 82152, Germany.
Hui-Yuan TsengDepartment of Molecular Medicine, Max Planck Institute of Biochemistry, Martinsried 82152, Germany.
Federico SaltarinDepartment of Oncology, University of Torino School of Medicine, Candiolo, Torino 10060, Italy.
Elena AstaninaDepartment of Oncology, University of Torino School of Medicine, Candiolo, Torino 10060, Italy.
Katarzyna I WolanskaDepartment of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool L69 3BX, UK.
Mark R MorganDepartment of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool L69 3BX, UK.
Martin J HumphriesWellcome Trust Centre for Cell-Matrix Research, Faculty of Biology, Medicine &Health, University of Manchester, Manchester M13 9PT, UK.
Massimo M SantoroDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, 10126 Torino, Italy.
Guido SeriniDepartment of Oncology, University of Torino School of Medicine, Candiolo, Torino 10060, Italy.ORCID 0000-0002-3502-8367
Donatella ValdembriDepartment of Oncology, University of Torino School of Medicine, Candiolo, Torino 10060, Italy.
Candiolo Cancer Institute · ITMax Planck Institute of Biochemistry · DEUniversity of Liverpool · GBUniversity of Turin · ITVIB-KU Leuven Center for Microbiology · BEWellcome Centre for Cell-Matrix Research · GB

Funding

Cancer Research UK 21671
6 · The paper itself

Abstract

Basolateral polymerization of cellular fibronectin (FN) into a meshwork drives endothelial cell (EC) polarity and vascular remodelling. However, mechanisms coordinating α5β1 integrin-mediated extracellular FN endocytosis and exocytosis of newly synthesized FN remain elusive. Here we show that, on Rab21-elicited internalization, FN-bound/active α5β1 is recycled to the EC surface. We identify a pathway, comprising the regulators of post-Golgi carrier formation PI4KB and AP-1A, the small GTPase Rab11B, the surface tyrosine phosphatase receptor PTPRF and its adaptor PPFIA1, which we propose acts as a funnel combining FN secretion and recycling of active α5β1 integrin from the trans-Golgi network (TGN) to the EC surface, thus allowing FN fibrillogenesis. In this framework, PPFIA1 interacts with active α5β1 integrin and localizes close to EC adhesions where post-Golgi carriers are targeted. We show that PPFIA1 is required for FN polymerization-dependent vascular morphogenesis, both in vitro and in the developing zebrafish embryo.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCells, CulturedEmbryo, NonmammalianFibronectinsGene Expression RegulationGolgi ApparatusHumansHuman Umbilical Vein Endothelial CellsIntegrin alpha5beta1Neovascularization, PhysiologicZebrafishAdaptor Proteins, Signal TransducingFibronectinsIntegrin alpha5beta1PPFIA1 protein, human

Identifiers

PMID27876801
PMCPMC5122980
OpenAlexW2549828536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.